CNS Spectr. 2008 Apr;13(4):301-3.

Development of tics in a thirteen-year-old male following atomoxetine use.

Source

Pediatric Neurology, Department of Child Health, University of Missouri-Columbia, Columbia, MO 65212, USA.

Abstract

Tics and Tourette syndrome are common comorbidities of patients diagnosed with attention-deficit/hyperactivity disorder (ADHD). One of the mainstay pharmacologic therapies for ADHD has been stimulants. However, this class of drugs has been associated with tic exacerbations, thus limiting their utility in this patients subgroup. Atomoxetine has been explored as an alternative treatment as one of the few non-stimulants available to treat ADHD. Early data identifies atomoxetine's influence on Tourette symptomatology to be not merely equivocal but potentially suppressive in the manifestation of tics. There are, however, case studies describing patients experiencing recurrences of tics following treatment with atomoxetine. We present a unique case of a patient, without any prior history of a movement disorder, who developed tics following a single dose of atomoxetine that did not improve until interventional therapy was initiated.

PMID:: 18408649; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

EBSCO

Medical

Molecular Biology Databases

Supplemental Content

Related citations

Tic exacerbation and precipitation during atomoxetine treatment in two children with attention-deficit hyperactivity disorder. [Int J Psychiatry Med. 2007]
Tic exacerbation and precipitation during atomoxetine treatment in two children with attention-deficit hyperactivity disorder.
Párraga HC, Párraga MI, Harris DK. Int J Psychiatry Med. 2007; 37(4):415-24.
Review Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents. [Paediatr Drugs. 2009]
Review Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.
Garnock-Jones KP, Keating GM. Paediatr Drugs. 2009; 11(3):203-26.
Concomitant use of atomoxetine and OROS-methylphenidate in a 10-year-old child suffering from attention-deficit/hyperactivity disorder with comorbid bipolar disorder and Tourette syndrome. [J Child Adolesc Psychopharmacol. 2006]
Concomitant use of atomoxetine and OROS-methylphenidate in a 10-year-old child suffering from attention-deficit/hyperactivity disorder with comorbid bipolar disorder and Tourette syndrome.
Jaworowski S, Benarroch F, Gross-Tsur V. J Child Adolesc Psychopharmacol. 2006 Jun; 16(3):365-70.
Atomoxetine use associated with onset of a motor tic. [J Child Adolesc Psychopharmacol. 2005]
Atomoxetine use associated with onset of a motor tic.
Ledbetter M. J Child Adolesc Psychopharmacol. 2005 Apr; 15(2):331-3.
Review Attention deficit hyperactivity disorder, tics and Tourette's syndrome: the relationship and treatment implications. A commentary. [Eur Child Adolesc Psychiatry. 2006]
Review Attention deficit hyperactivity disorder, tics and Tourette's syndrome: the relationship and treatment implications. A commentary.
Robertson MM. Eur Child Adolesc Psychiatry. 2006 Feb; 15(1):1-11.

See reviews... See all...

Cited by 2 PubMed Central articles

European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment. [Eur Child Adolesc Psychiatry. 2011]
European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment.
Roessner V, Plessen KJ, Rothenberger A, Ludolph AG, Rizzo R, Skov L, Strand G, Stern JS, Termine C, Hoekstra PJ, et al. Eur Child Adolesc Psychiatry. 2011 Apr; 20(4):173-96.
European guidelines on managing adverse effects of medication for ADHD. [Eur Child Adolesc Psychiatry. 2011]
European guidelines on managing adverse effects of medication for ADHD.
Graham J, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Dittmann RW, Döpfner M, Hamilton R, Hollis C, Holtmann M, et al. Eur Child Adolesc Psychiatry. 2011 Jan; 20(1):17-37. Epub 2010 Nov 3.

Chemical compound information

atomoxetine

MW: 255.35 g/mol

MF: C₁₇H₂₁NO

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Development of tics in a thirteen-year-old male following atomoxetine use.
Development of tics in a thirteen-year-old male following atomoxetine use.
CNS Spectr. 2008 Apr ;13(4):301-3.

PubMed
Evidence-based psychosocial treatments for attention-deficit/hyperactivity disor...
Evidence-based psychosocial treatments for attention-deficit/hyperactivity disorder.
J Clin Child Adolesc Psychol. 2008 Jan ;37(1):184-214.

PubMed
Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome.
Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome.
Endocr Pract. 2002 Nov-Dec ;8(6):417-23.

PubMed
Antagonistic pleiotropic effects reduce the potential adaptive value of the FRIG...
Antagonistic pleiotropic effects reduce the potential adaptive value of the FRIGIDA locus.
Proc Natl Acad Sci U S A. 2007 Oct 23 ;104(43):16986-91. Epub 2007 Oct 16 .

PubMed
Suicide in prisoners: a systematic review of risk factors.
Suicide in prisoners: a systematic review of risk factors.
J Clin Psychiatry. 2008 Nov ;69(11):1721-31. Epub 2008 Nov 4 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Development of tics in a thirteen-year-old male following atomoxetine use.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

Supplemental Content

Related citations

Cited by 2 PubMed Central articles

Chemical compound information

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information